Foster Dykema Cabot & Partners’s Thermo Fisher Scientific TMO Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.2M	Sell	45,103 -137	-0.3%	-$74.3K	1.41%	24
2025 Q4	$26.2M	Buy	45,240 +514	+1%	+$291K	1.61%	20
2025 Q3	$21.7M	Sell	44,726 -223	-0.5%	-$104K	1.42%	26
2025 Q2	$18.2M	Buy	44,949 +62	+0.1%	+$25.9K	1.28%	25
2025 Q1	$22.4M	Sell	44,887 -425	-0.9%	-$230K	1.79%	20
2024 Q4	$23.6M	Buy	45,312 +2,173	+5%	+$1.19M	1.84%	20
2024 Q3	$26.7M	Sell	43,139 -2	-0%	-$1.18K	2.24%	16
2024 Q2	$23.9M	Buy	43,141 +424	+1%	+$243K	2.14%	20
2024 Q1	$24.8M	Buy	42,717 +695	+2%	+$390K	2.31%	17
2023 Q4	$22.3M	Buy	+42,022	New	+$20.3M	2.36%	15

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Foster Dykema Cabot & Partners's TMO Position: Q1 2026 in Review

Foster Dykema Cabot & Partners reduced its Thermo Fisher Scientific (TMO) stake by 0.3% in Q1 2026, selling an estimated $74.3K and leaving 45,103 shares worth $22.2M. The position accounts for 1.41% of the portfolio, ranked #24.

Foster Dykema Cabot & Partners first reported a position in TMO in Q4 2023 and has held it in 10 quarters since. The position peaked at $26.7M in Q3 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Foster Dykema Cabot & Partners held 45,103 shares of Thermo Fisher Scientific worth $22.2M as of Q1 2026.
Foster Dykema Cabot & Partners sold 137 Thermo Fisher Scientific shares in Q1 2026, an estimated $74.3K.
Thermo Fisher Scientific made up 1.41% of Foster Dykema Cabot & Partners's portfolio in Q1 2026, its #24 holding.
Foster Dykema Cabot & Partners first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 10 quarters since.
Foster Dykema Cabot & Partners's Thermo Fisher Scientific position peaked at $26.7M in Q3 2024.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q1 2026, filed 14 May 2026.